Crisaborole 2% ointment as an effective and safe option in mild to moderate atopic dermatitis: data from a pilot study
Crisaborole might emerge as a potential long-term therapeutic option in not only paediatric patients but also in adult patients with mild to moderate atopic dermatitis. Our pilot study, carried out on a cohort of Indian patients, emphasizes the safety, reliability and efficacy of this novel molecule on atopic dermatitis.
Authors
- Abheek Sil (ORCID: https://orcid.org/0000-0002-8043-2721)
- Rashmi Sarkar
Institutions
- Lady Hardinge Medical College (IN)
- Bengbu Medical College (CN)
- KPC Medical College and Hospital (IN)
- R. G. Kar Medical College and Hospital (IN)
- Medical College and Hospital, Kolkata (IN)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1093/ced/llae534
- Citations
- 1
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.53